TP53BP2 and metabolic dysfunction-associated steatotic liver disease: Western blot data demonstrated that ASPP2 is lower and the LC3-II/I ratio is higher in the NAFLD samples compared with the normal liver tissue (Fig. 6C–E), which further suggests that ASPP2 may play a role in NAFLD.